Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2D
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2D
Authors
Keywords
-
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 205, Issue -, Pages 110977
Publisher
Elsevier BV
Online
2023-10-25
DOI
10.1016/j.diabres.2023.110977
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetes
- (2023) Kerstin Brismar et al. Frontiers in Endocrinology
- Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort
- (2022) Diana Hedevang Christensen et al. BMJ Open Diabetes Research & Care
- Risk factors associated with mortality among individuals with type 2 diabetes and depression across two cohorts
- (2022) Christopher Rohde et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance
- (2021) Hatim Boughanem et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development of a novel assay for IGFBP-2 complexed with IGF-I and-II in human serum
- (2020) Jonas Agerholm et al. GROWTH HORMONE & IGF RESEARCH
- Mechanisms of action of metformin with special reference to cardiovascular protection
- (2019) Alexey V. Zilov et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Circulating IGFBP‐2: a novel biomarker for incident dementia
- (2019) Emer R. McGrath et al. Annals of Clinical and Translational Neurology
- Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool
- (2018) Jacob V. Stidsen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
- (2018) Diana Hedevang Christensen et al. BMJ Open
- Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort study
- (2018) Ulrick Espelund et al. Cancer Medicine
- Current IGFBP-Related Biomarker Research in Cardiovascular Disease—We Need More Structural and Functional Information in Clinical Studies
- (2018) Andreas Hoeflich et al. Frontiers in Endocrinology
- The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes
- (2018) Natalie J. Haywood et al. Molecular Metabolism
- IGFBP-2 and aging: a 20-year longitudinal study on IGFBP-2, IGF-I, BMI, insulin sensitivity and mortality in an aging population
- (2018) Annewieke W van den Beld et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage
- (2017) Rikke Hjortebjerg et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2
- (2016) K M Biernacka et al. ENDOCRINE-RELATED CANCER
- Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states
- (2016) Hye Suk Kang et al. Scientific Reports
- IGFBP-2: The dark horse in metabolism and cancer
- (2015) V.C. Russo et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed Type 2 diabetes
- (2015) A. Mor et al. DIABETIC MEDICINE
- IGF-binding protein 2 is a candidate target of therapeutic potential in cancer
- (2015) Xiaofeng Yao et al. TUMOR BIOLOGY
- The Danish National Patient Registry: a review of content, data quality, and research potential
- (2015) Morten Schmidt et al. Clinical Epidemiology
- IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes
- (2014) S W Yau et al. INTERNATIONAL JOURNAL OF OBESITY
- Determination of IGFs and their binding proteins
- (2013) Rikke Hjortebjerg et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes
- (2013) Rikke Hjortebjerg et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- High IGFBP2 levels are not only associated with a better metabolic risk profile but also with increased mortality in elderly men
- (2012) A. W. van den Beld et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system
- (2012) Jens Steen Nielsen et al. Clinical Epidemiology
- Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions
- (2012) Sigrun Alba Johannesdottir et al. Clinical Epidemiology
- Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
- (2010) Kristina Hedbacker et al. Cell Metabolism
- Plasma Insulin-Like Growth Factor-Binding Protein-2 Levels as Diagnostic and Prognostic Biomarker of Colorectal Cancer
- (2010) Jyh-Ming Liou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis
- (2009) Stephen B. Wheatcroft et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation